Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

European shares rise on real estate boost

by Jessica Weisman-Pitts
0 comments
2024 09 10T073156Z 1 LYNXMPEK8907R RTROPTP 4 EUROPE STOCKS

By Pranav Kashyap

(Reuters) – European shares climbed on Tuesday, boosted by the real-estate sector, while investors also awaited the widely expected rate cut by the European Central Bank later in the week.

The pan-European STOXX 600 index rose 0.3% after gaining nearly 1% on Monday.

Rate-sensitive real estate sector advanced 1% ahead of the ECB’s interest rate decision on Thursday.

With markets fully pricing in a 25 basis-point cut this week, investors will keep a close eye on cues on likely rate cuts in October and December.

“I don’t think the ECB would prefer to be too dovish at this point. There’s no growth mandate for ECB, compared to the Fed that has a dual mandate,” said Geoff Yu, senior macro strategist at BNY.

“Developments on the other side of the pond are still the main drivers of sentiment right now. The balance is probably a bit too lopsided in favour of the Fed.”

Given the dominance of U.S. data, traders were also focused on Wednesday’s inflation report, which could provide clarity on the size of the Federal Reserve’s rate cut when it meets next week.

The first debate between U.S. presidential candidates Democrat Kamala Harris and Republican Donald Trump ahead of the Nov. 5 election is due later in the day.

“There will be direct observance of the event. This is not just the U.S. story… it’s much more for European story as well, given the tax burden that Europe faces,” BNY’s Yu said.

Germany’s DAX ticked up 0.2% after data showed the country’s inflation slowed to 2% in August.

Elsewhere, British labour data showed average weekly earnings, excluding bonuses, were 5.1% higher than a year earlier in the three months to the end of July.

It’s benchmark FTSE 100 was down 0.4%.

The STOXX was also supported by gains in technology companies. Capgemini and SAP SE gained 7% and 0.7%, respectively, after Oracle’s upbeat results.

Heavy-weight AstraZeneca shed 5.1%, capping the STOXX’s gains, after detailed study results showed its experimental lung cancer drug did not significantly improve patients’ overall survival results.

The healthcare sector lost 0.8%.

Hearing aid companies were the biggest percentage decliners after Apple said its new Airpods can work as hearing aids. Amplifon fell about 6%, Sonova, Demant and GN Store Nord lost between 3% and 4%.

 

(Reporting by Pranav Kashyap in Bengaluru; Editing by Savio D’Souza and Eileen Soreng)

 

Recent Post